JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SMITH, R. P.
Right arrow Articles by THRON, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SMITH, R. P.
Right arrow Articles by THRON, C. D.
Journal of Pharmacology And Experimental Therapeutics, Vol. 183, Issue 3, 549-558, 1972
Copyright © 1972 by American Society for Pharmacology and Experimental Therapeutics

HEMOGLOBIN, METHYLENE BLUE AND OXYGEN INTERACTIONS IN HUMAN RED CELLS

ROGER P. SMITH 1 and C. D. THRON 1

1 Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire

Methylene blue is employed therapeutically in the management of acute, acquired methemoglobinemia to accelerate reductive processes in the red cell. In normal humans or laboratory animals, however, controversy has existed for many years about the paradoxical ability of methylene blue to generate low levels of methemoglobin. Under physiological conditions human red cells maintain an equilibrium between methemoglobin and hemoglobin which favors the latter to the extent of 95 to 98%. Results presented here confirm that methylene blue accelerates the rate of hemoglobin-methemoglobin turnover with only minor shifts in the equilibrium of the reaction. This accelerated turnover does not contribute significantly to the steady-state oxygen consumption of red cells exposed to methylene blue. The latter is partially blocked by N-ethylmaleimide whereas the oxygen consumption of red cells in the absence of methylene blue is inhibited by high concentrations of cyanide. Under artificial conditions in vitro methylene blue can significantly alter the equilibrium between hemoglobin and methemoglobin to greatly favor the latter. In order of decreasing importance, factors which favor methemoglobin formation by methylene blue include: hemolysis, low oxygen tensions and illumination. Factors which favor methemoglobin reduction include: intact red cells and low oxygen tensions. Both methemoglobin formation and methemoglobin reduction by methylene blue are concentration-dependent phenomena, and the stoichiometry of the reactions indicate that in either case the dye is recycled many times.

Submitted on May 1, 1972
Accepted on June 27, 1972




This article has been cited by other articles:


Home page
 Am. J. Physiol. Cell Physiol.Home page
J. M. May, Z.-c. Qu, and C. E. Cobb
Reduction and uptake of methylene blue by human erythrocytes
Am J Physiol Cell Physiol, June 1, 2004; 286(6): C1390 - C1398.
[Abstract] [Full Text] [PDF]

Home page
 Occup. Environ. Med.Home page
S. M Bradberry, T.-C. Aw, N. R Williams, and J A. Vale
OCCUPATIONAL METHAEMOGLOBINAEMIA
Occup. Environ. Med., September 1, 2001; 58(9): 611 - 611.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
H. Gourlain, F. Buneaux, S. W. Borron, B. Gouget, and P. Levillain
Interference of Methylene Blue with CO-Oximetry of Hemoglobin Derivatives
Clin. Chem., June 1, 1997; 43(6): 1078 - 1080.
[Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1972 by the American Society for Pharmacology and Experimental Therapeutics.